Ireland· IE-PA-PA23250/011/001
Eltrombopag MSN 25 mg film-coated tablets
A eltrombopag product containing eltrombopag olamine, registered in Ireland by MSN Labs Europe Limited. The same ATC class is registered in 15 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Eltrombopag is registered in 15 of 19 countries.
Countries holding a registration under ATC B02BX05 (eltrombopag), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Eltrombopag · ATC B02BX05
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of eltrombopag costs, country by country.
Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Eltrombopag · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$38.37
The record
At a glance
HPRA (Ireland)- Active substance
- Eltrombopag olamine
- Manufacturer
- MSN Labs Europe Limited
- Country
- Ireland (IE)
- ATC code
- B02BX05
- ATC class
- Eltrombopag
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA23250/011/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
175 interactions on record for eltrombopag.
Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eltrombopag · interactions on record
175 records
- 20 severe
- 153 moderate
- 2 minor
Most severe, free to view
- EluxadolineA07DA06severe
- BerotralstatB06AC06severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eltrombopag in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaELTROMBOPAG ABDIAbdi Farma GmbH, Heppenheim
- United StateseltrombopagDr. Reddy's Laboratories Inc.,
- FinlandEltrombopag AccordAccord Healthcare S.L.U.
- FranceELTROMBOPAG BIOGARAN 25 mg, comprimé pelliculéBIOGARAN
- BelgiumEltrombopag AB 25 mgAurobindo
- SwedenEltrombopag Teva GmbH 25 mg Filmdragerad tablettTEVA GmbH
- NorwayEltrombopag ZentivaZentiva k.s.
- GermanyEltrombopag ZentivaZentiva Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Eltrombopag Ratiopharm
- Belgium · Eltrombopag Ab
- Bulgaria · Елтромбопаг Pht, Елтромбопаг Тева
- Czechia · Eltrombopag Teva
- Germany · Eltrombopag Ratiopharm, Eltrombopag Zentiva
- Denmark · Eltrombopag Zentiva
- Estonia · Eltrombopag Zentiva
- Spain · Eltrombopag Teva, Eltrombopag Zentiva
- France · Eltrombopag Arrow, Eltrombopag Sandoz
- United Kingdom (Northern Ireland) · Eltrombopag Tilllomed, Eltrombopag Tillomed
- Greece · Eltrombopag Ariti
- Croatia · Rulemya 25 Mg Tablete, Rulemya 50 Mg Tablete
- Italy · Eltrombopag Teva, Eltrombopag Zentiva
- Lithuania · Eltrombopag Teva, Eltrombopag Zentiva
- Luxembourg · Eltrombopag Ab
- Netherlands · Eltrombopag Aurobindo, Eltrombopag Teva
- Norway · Eltrombopag Teva, Eltrombopag Zentiva
- Poland · Eltrombopag Zentiva
- Portugal · Eltrombopag Generis, Eltrombopag Generis Phar
- Sweden · Eltrombopag Teva Gmbh, Eltrombopag Zentiva
- Slovakia · Eltrombopag Sandoz, Eltrombopag Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b9502050-d8b3-4b59-9f7b-c73a8994b5a2 GET /v1/drugs/b9502050-d8b3-4b59-9f7b-c73a8994b5a2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"B02BX05"
],
"strength": null,
"pa_number": "PA23250/011/001",
"substances": [
"Eltrombopag olamine"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "04/04/2025",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": "IC0198-022-003"
}See everything about eltrombopag.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.